Current Assets

Derivative Assets, Current

Biogen Derivative Assets, Current increased by 91.0% to $19.10M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2014
Last reportedQ1 2026
Metric ID: derivative_assets_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$10.00M$19.10M
QoQ Change—+91.0%
Range$10.00M – $19.10M

Frequently Asked Questions

What is Biogen's derivative assets, current?
Biogen (BIIB) reported derivative assets, current of $19.10M in Q1 2026.